Summary Background Several SARS-CoV-2 variants of concern have been identified that
partly escape serum neutralisation elicited by current vaccines. Studies have also shown …

Both previous infection and vaccination have been shown to provide potent protection from
COVID-19. However, there are concerns that waning immunity and viral variation may lead …

Vaccine protection from symptomatic SARS-CoV-2 infection has been shown to be strongly
correlated with neutralising antibody titres; however, this has not yet been demonstrated for …

Antibody responses against the SARS-CoV-2 Spike protein correlate with protection against
COVID-19. Serum neutralizing antibodies appear early after symptom onset following SARS …

Background: Recently emerged SARS-CoV-2 variants may pose a threat to immunity
derived from prototypical SARS-CoV-2 infection or vaccination. A systematic summary of the …

Predictive models of immune protection from COVID-19 are urgently needed to identify
correlates of protection to assist in the future deployment of vaccines. To address this, we …

Understanding the impact of prior infection with severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) on the response to vaccination is a priority for responding to …

One year in the coronavirus disease 2019 (COVID-19) pandemic, the first vaccines are
being rolled out under emergency use authorizations. It is of great concern that newly …

Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the virus
responsible of the current pandemic ongoing all around the world. Since its discovery in …

Emerging SARS-CoV-2 variants raise questions about escape from previous immunity. As
the population immunity to SARS-CoV-2 has become more complex due to prior infections …